Keyvantage Wealth’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,163
Closed -$202K 97
2025
Q4
$202K Buy
+1,163
New +$212K 0.09% 99

Other funds holding INSM

Keyvantage Wealth's INSM Position: Q1 2026 in Review

Keyvantage Wealth sold out of Insmed (INSM) in Q1 2026, closing a stake of 1,163 shares — an estimated $202K sold.

Keyvantage Wealth first reported a position in INSM in Q4 2025 and held it in 1 quarter. The position peaked at $202K in Q4 2025. 674 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Keyvantage Wealth reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Keyvantage Wealth sold 1,163 Insmed shares in Q1 2026, an estimated $202K.
  • Keyvantage Wealth first reported a position in Insmed in Q4 2025 and held it in 1 quarter.
  • Keyvantage Wealth's Insmed position peaked at $202K in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Keyvantage Wealth's 13F filing for Q1 2026, filed 5 May 2026.